Glaxo set for big push into cancer medicine
626533
GlaxoSmithKline Plc is preparing for a  "renaissance" of its oncology business, led by Tykerb, a novel  pill that is expected to win U.S. regulatory approval for  breast cancer next month.
279186
WASHINGTON The first new cancer drug in ten years that is specifically designed to help children is a step closer to approval. An advisory panel at the Food and Drug Administration is recommending the use
310317
The new drug could become the first effective treatment for liver cancer, one of the deadliest forms of cancer.
534244
TUESDAY, March 13 (HealthDay News) -- GlaxoSmithKline&#39;s Tykerb (lapatinib) has been approved by the U.S. Food and Drug Administration to treat advanced breast cancer when other cancer drugs haven&#39;t succeeded, the agency said Tuesday.
516107
WASHINGTON - GlaxoSmithKline PLC's Avandia, the world's best-selling diabetes drug last year, will carry US regulators' strongest warning on the risk of heart attacks.
145678
Doctors are hopeful about a new drug to treat skin cancer by causing tumor cells to self-destruct by overloading them with oxygen.
320147
Cancer drug shows exceptional promise as it moves toward FDA review.
641201
A preview of some of the biopharmas presenting at the American Society of Clinical Oncology conference.
331079
GlaxoSmithKline Plc GSK.L has agreed  to disclose information on all clinical studies of its drugs to  settle a lawsuit that accused it of withholding negative  information about the antidepressant Paxil, the New York  Attorney General's office said on Thursday.
156434
An experimental cancer drug made by Abbott Laboratories Inc. passed its first round of human testing about six months faster than usual, thanks to a new program that aims to speed drug development.
265727
GlaxoSmithKline said on Tuesday that U.S. health regulators granted a priority review to a capsule form of its drug Hycamtin for the treatment of relapsed small cell lung cancer.
736874
In a settlement that the New York State attorney general said would transform the drug industry, GlaxoSmithKline has agreed to post on its Web site the results of all clinical trials involving its drugs.
506148
It's running trials to see if the drug can be used in earlier stages of cancer.
432368
The finding will help doctors make better treatment  decisions and may give rise to a new way of halting the advance  of breast cancer, said Dr. Sohail Tavazoie, an oncologist at  Memorial Sloan-Kettering Cancer Center in New York.
521788
GlaxoSmithKline's cervical cancer vaccine gets a positive recommendation.
138104
Human Genome Sciences could see more than $180 million from a new deal with drug maker GlaxoSmithKline. Glaxo has acquired exclusive rights to an experimental drug called Albugon, which Human Genome Sciences
531441
GlaxoSmithKline Plc announced further clinical trial results on Sunday underlining the ability of a drug combination including its product Tykerb to fight breast cancer that has spread to the brain.